| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 74.757 | 131.476 | 223.386 | 165.676 | 200.039 | 204.872 | 215.795 | 354.493 | 582.033 |
| Total Income - EUR | 0 | 74.758 | 131.483 | 226.385 | 165.776 | 200.045 | 205.694 | 215.796 | 354.527 | 595.695 |
| Total Expenses - EUR | 1.664 | 82.106 | 136.504 | 236.583 | 166.123 | 185.531 | 197.568 | 213.403 | 342.526 | 587.909 |
| Gross Profit/Loss - EUR | -1.664 | -7.348 | -5.022 | -10.198 | -347 | 14.513 | 8.126 | 2.393 | 12.001 | 7.787 |
| Net Profit/Loss - EUR | -1.664 | -8.099 | -6.338 | -12.467 | -2.005 | 13.214 | 6.230 | 607 | 9.151 | 6.392 |
| Employees | 1 | 2 | 2 | 5 | 2 | 2 | 2 | 2 | 4 | 6 |
Check the financial reports for the company - Euphorbium Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.462 | 16.052 | 14.147 | 8.611 | 4.534 | 1.650 | 14.865 | 35.739 | 25.347 | 33.562 |
| Current Assets | 1.845 | 25.556 | 33.212 | 52.314 | 41.439 | 56.175 | 49.374 | 55.804 | 108.936 | 179.094 |
| Inventories | 375 | 14.717 | 17.248 | 16.216 | 19.910 | 24.541 | 25.558 | 29.360 | 54.630 | 90.495 |
| Receivables | 1.304 | 2.637 | 13.105 | 34.013 | 18.580 | 27.095 | 21.489 | 24.337 | 44.357 | 73.285 |
| Cash | 165 | 8.203 | 2.860 | 2.085 | 2.949 | 4.539 | 2.327 | 2.107 | 9.948 | 15.314 |
| Shareholders Funds | -1.619 | -9.702 | -15.876 | -28.052 | -29.303 | -15.533 | -8.959 | -8.379 | 797 | 7.184 |
| Social Capital | 45 | 45 | 44 | 43 | 253 | 248 | 243 | 243 | 243 | 241 |
| Debts | 15.926 | 51.310 | 63.235 | 88.977 | 75.276 | 73.358 | 73.198 | 99.922 | 133.486 | 205.472 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Euphorbium Pharm Srl